Everstone Acquires Significant Stake in Apothecon Group for $270 Million

Mumbai: Everstone Capital to Invest $270 Million in Apothecon Group

Singapore-based private equity firm Everstone Capital has announced plans to invest close to $270 million in Apothecon Group, a multinational company with operations in India and the United States. The investment will be aimed at acquiring a significant stake in the group, which comprises India-based Apothecon and US-based Navinta.

The investment deal was confirmed in a statement released by Everstone Capital on Tuesday. The exact terms of the deal remain unclear, but the investment is expected to bolster the growth prospects of Apothecon Group's various businesses.

Apothecon Group's operations in India and the United States will likely benefit from the influx of capital, allowing the company to expand its offerings and strengthen its market position. The investment by Everstone Capital is set to be a significant development in the Indian and US markets, where Apothecon Group already has a substantial presence.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Everstone Capital has a reputation for making strategic investments in various sectors, including healthcare and consumer goods. The company has a significant portfolio of investments across Asia and the United States, and its latest move is likely to further cement its position as a major player in the global private equity market.